Contact NAMA

Similar Posts

  • Category: Press Release

    Admin 07/14/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • Patient “vs” Client

    Admin 12/04/2022

    Policy Statement Number 4 May 1994 Over the years methadone providers and patients have begun using client in place of patient. While this maybe well intended NAMA is concerned that the results could become damaging to methadone treatment, and most especially to patients. The use of client is deprogating to methadone patients, inferring that their…

  • The National Methadone Conference-1

    Admin 02/12/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Honorary Patient Recognition The Honorary Methadone Patient was developed by the National Alliance of Methadone Advocates to recognize those special persons who are not patients but in addition to making significant contributions to the field do so to help patients. Dr….

  • In Support of Medication-Assisted Treatment

    Admin 09/11/2021

    Policy Statement Number 12 May 2003 For the past thirty-five years the only effective treatment for opiate addiction has been methadone treatment. From the start methadone treatment has been evaluated world wide with some studies that continue to this day. These studies are remarkably consistent in demonstrating that no matter what country, ethnicity, sex, education…

  • In Memory of John Mordaunt

    Admin 09/11/2022

    John Mordaunt was a tireless advocate of HIV infected drug users. He was the first HIV+ drug user to be shown on national television in his country, England. Mordaunt helped to found the British advocacy organization for HIV infected drug users called Frontliners and was active with the European Interest Group on Drug Policy, a…